tazobactam has been researched along with Mycoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bornhauser, M; Ehninger, G; Hanel, M; Kroschinsky, F; Ordemann, R; Schuler, U; Wichmann, G | 1 |
| Antretter, H; Bonatti, H; Guggenbichler, JP; Ladurner, R; Laesser, R; Margreiter, R; Mark, W; Muehlmann, G; Stelzmueller, I; Tabarelli, D; Tabarelli, W; Wiesmayr, S; Zimmerhackl, LB | 1 |
2 other study(ies) available for tazobactam and Mycoses
| Article | Year |
|---|---|
Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/tazobactam in patients undergoing hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Bacterial Infections; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Penicillanic Acid; Pilot Projects; Piperacillin; Tazobactam; Transplantation, Autologous; Transplantation, Homologous | 2002 |
Experience with the use of piperacillin-tazobactam in pediatric non-renal solid organ transplantation.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Mycoses; Organ Transplantation; Penicillanic Acid; Piperacillin; Tazobactam | 2007 |